FBC represented Applied Immune Technologies Ltd. (“AIT”), a drug development company specializing in therapeutic applications for cancer and other autoimmune diseases, owned by Technion Research and Development Foundation Ltd., Technion Investment Opportunities Fund, OrbiMed Israel Partners Limited Partnership, Novartis Bioventures Ltd., Pontifax funds and others, in a complex merger transaction for the purchase and sale […]
General Search
Practice Area
Attorney
Date
Publication Type
